Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, Inc. (RAPP), sold 2,210 shares at $42.11 ($93K) on 2026-07-27, disclosed to the SEC on 2026-07-29.
Scheduled sale ($93k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.11 | 2,203 | $93K | 99.7% |
| 2 | $42.73 | 7 | $299 | 0.3% |
| Total | $42.11 avg | 2,210 | $93K | 100% |
| Filing → |
| RAPP | SELL | 2026-08-26 | $938K | — | Filing → |
| RAPP | SELL | 2026-08-12 | $2.4M | — | Filing → |
| RAPP | SELL | 2026-07-15 | $328K | — | Filing → |